Tempest Therapeutics, Inc. (TPST) Net income 2016–2025
Tempest Therapeutics, Inc. (TPST) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$26.3MFY2025 · since FY2016: -$82.3M → -$26.3M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$26.3M | +37.2% |
| FY2024 | -$41.8M | -41.9% |
| FY2023 | -$29.5M | +17.4% |
| FY2022 | -$35.7M | -26.2% |
| FY2021 | -$28.3M | -47.3% |
| FY2020 | -$19.2M | +56.9% |
| FY2019 | -$44.6M | -63.9% |
| FY2018 | -$27.2M | +67.8% |
| FY2017 | -$84.6M | -2.8% |
| FY2016 | -$82.3M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More TPST financial trends
TPST RevenueTPST Net marginTPST Gross profitTPST Gross marginTPST Operating incomeTPST Operating marginTPST Operating cash flowTPST Free cash flowTPST Capital expendituresTPST Return on equityTPST Stock buybacksTPST Dividends paidTPST Total assetsTPST Total liabilitiesTPST Shareholders’ equityTPST overview →